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ABSTRACT  |  The study aimed to identify and compare 
the ratings of perceived exertion (RPE) at the ventilatory 
anaerobic threshold (VAT) in healthy subjects and patients 
with coronary artery disease (CAD). A total of 30 male sub-
jects took part in the study and were divided into three 
groups: a control group (CG) composed of 10 healthy par-
ticipants; a group composed of 10 participants diagnosed 
with CAD beta-blocker user (G-DACb); and a group com-
posed of 10 participants with CAD non-beta-blocker user 
(G-DAC). The participants performed a cardiopulmonary 
exercise test (CPET) with continuous type ramp protocol 
to determine the VAT, through the visual graphical analy-
sis (loss of parallelism between the oxygen uptake and 
the carbon dioxide output). During CPET, before the end 
of each one-minute period, the subjects were asked to 
rate dyspnea (RPE-D) and leg fatigue (RPE-L) on the Borg 
CR-10 scale. After the VAT was determined, the score that 
the participants gave on the Borg CR10 scale was verified. 
CG participants showed higher workload, oxygen uptake, 
carbon dioxide output, ventilation and heart rate at the VAT 
compared to the G-DAC and G-DACb (p<0.05). However, 
regarding the RPE-L and the RPE-D, no significant differ-
ence between the groups were observed (p<0.05). Values 
between five and six on Borg CR-10 scale matched the VAT 
in the subjects studied. However, other parameters must 
be concomitantly used for prescribing exercise intensity 
in physical training protocols, at levels close to the VAT for 
patients with CAD.
Keywords  |  Coronary Disease; Exercise Test; Ratings of 
Perceived Exertion.
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RESUMO  |  O objetivo do estudo foi identificar e comparar 
a percepção subjetiva do esforço (PSE) no limiar anaeróbio 
ventilatório (LAV) em indivíduos saudáveis e com doença 
arterial coronariana (DAC). Foram estudados 30 homens, 
sendo 10 saudáveis que constituíram o grupo controle (GC) 
e 20 diagnosticados com DAC, dos quais 10 faziam uso de 
medicamento betabloqueador (G-DACb) e 10 não faziam 
uso (G-DAC). Os voluntários foram submetidos a um teste 
de exercício cardiopulmonar (TECP) com protocolo contí-
nuo tipo rampa para determinação do LAV, através da aná-
lise visual gráfica (perda do paralelismo entre o consumo 
de oxigênio e a produção de dióxido de carbono). Durante 
a realização do TECP, foi solicitado aos voluntários que re-
latassem ao final de cada minuto a percepção subjetiva 
do esforço de membros inferiores (PSE-M) e a percepção 
subjetiva do esforço respiratório (PSE-R), através da escala 
CR-10 de Borg. O GC apresentou maiores valores de potên-
cia, consumo de oxigênio, produção de dióxido de carbono, 
ventilação e frequência cardíaca no LAV comparado aos 
grupos G-DAC e G-DACb (p<0,05). A PSE-M foi menor no 
G-DACb comparado ao GC (p<0,05). Após ajuste pela co-
variável potência, não houve diferença significativa entre 
os grupos para PSE-M e PSE-R (p>0,05). Valores entre cin-
co e seis na escala CR-10 de Borg correspondeu ao LAV na 
amostra estudada. Entretanto, outros parâmetros devem 
ser utilizados concomitantemente para a prescrição da in-
tensidade de exercício nos protocolos de treinamento físico, 
em níveis próximos ao LAV para pacientes com DAC.
Descritores  |  Doença das Coronárias; Teste de Esforço; 
Percepção Subjetiva de esforço.
DOI: 10.1590/1809-2950/37321022014
114
Fisioter Pesq. 2014;21(2):113-119
INTRODUCTION
A sedentary lifestyle has been considered the main 
modifiable risk factor for coronary artery disease 
(CAD)1. On the other hand, regular physical exercise 
can reduce cardiac mortality from 20 to 30% along with 
lifestyle changes2. However, the dropout rate in physical 
conditioning programs and cardiac rehabilitation is ap-
proximately 45%3.
One of the main problems related to adhering to 
physical exercise programs is the difficulty to achieve 
and maintain the intensity prescribed for training4. 
Workouts performed at an inadequate intensity can 
yield limited benefits and even be unfavorable, raising 
cardiovascular and orthopedic risks.
Some authors5 report that intensities close to the 
ventilatory anaerobic threshold (VAT), the level of 
physical exercise at which the production of energy by 
the aerobic metabolism is supplemented by the anaero-
bic metabolism6, are an indispensable parameter for ef-
fective training and are also safe in regards to potential 
cardiovascular events.
These observations have renewed the attention 
drawn toward the potential for alternative approaches 
and auxiliary tools, such as the rating of perceived ex-
ertion (RPE), used to prescribe and monitor exercise 
intensity in healthy individuals and those with cardio-
vascular disease7,8.
The Borg CR-10 Scale is a scale composed of num-
bers related to verbal expression used to determine de-
grees of intensity7,9. However, although some authors 
have determined RPE degrees at the moment of VAT 
in healthy individuals10,11, there is a scarcity of studies 
with individuals with CAD who use and do not use 
beta-blocker medication.
In other studies, researchers report that cardiac dis-
ease and the use of beta-blockers can induce alterations 
related to RPE, reducing tolerance to exercise and in-
creasing the perception of effort about the same exercise 
intensity12-14. Thus, in the present study our purpose was 
to identify and compare the RPE values in relation to 
lower limbs (RPE-L) and dyspnea (RPE-D) at the mo-
ment of VAT between healthy individuals and patients 
with CAD who used and did not use beta-blocker 
medication. We also aimed at verifying the relation of 
ventilatory and metabolic variables and power in Watts 
(W) with RPE.
METHODS  
Participants
The participants were 30 male individuals allocated in 
three groups. One group was composed by 10 volun-
teers with clinical diagnosis of CAD who did not use 
beta-blocker medication (CAD-G); the second group 
counted 10 volunteers who also had  clinical diagnoses 
but used beta-blockers (CADb-G); and 10 healthy in-
dividuals who composed the control group (CG).
In the groups with CAD, we included the volunteers 
who presented a reduction in coronary luminal diam-
eter larger than or equal to 50% in at least one coronary 
artery, determined by a coronary angiogram15 and who 
had been submitted to angioplasty at least 3 months 
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prior to the present study. Volunteers with osteomyoar-
ticular diseases or disorders were excluded. 
To be included in the CG, the individuals had to 
present normal results in the biochemical exams and 
in an electrocardiogram (ECG); they could not have 
cardiovascular, respiratory, osteomyoarticular and meta-
bolic diseases; make no use of any type of medication; 
and not consume tobacco, alcohol or drugs that caused 
chemical dependence.
This study was approved by the Ethics Committee 
of the institution in question. Only the individuals who 
signed the Informed Consent form were included.
Procedures 
The experimental procedures were conducted in a cli-
matized laboratory, with the temperature and relative 
air humidity maintained at approximately 23ºC and 
60%, respectively. The volunteers were familiarized 
with the laboratory and the experimental protocol 
the day before the test. On the day of the test, they 
were asked about their health condition and whether 
they had followed the recommendations to avoid the 
ingestion of alcoholic or stimulating beverages (cof-
fee, tea, soda) and extenuating physical exercises. 
Before the protocol was carried out, the volunteers 
remained in the supine position for 15 minutes so 
that their blood pressure, heart rate (HR) and ECG 
at rest could be measured with the purpose of verify-
ing whether their basal conditions were satisfactory 
to carry on with the experiment. We considered as 
unsatisfactory conditions alterations in blood pres-
sure and/or HR in comparison to the rates obtained 
on the day of familiarization, or the presence of al-
terations or abnormalities on the ECG.
Experimental protocol
The experiment consisted of a cardiopulmonary ex-
ercise test (CPET) with a continuous ramp protocol, 
performed on a cycle ergometer with electromagnetic 
brakes (Quinton Corival 400) and adjusted seat so as to 
allow for about 5 to 10o of knee flexion. The volunteers 
were instructed to maintain their pedaling rate at 60 ro-
tations per minute (rpm) and to not perform isometric 
contraction of their upper limbs during the test.
The CPET consisted of 1 minute of rest on the cycle 
ergometer in the sitting position, followed by 4 minutes 
of warm-up pedaling at 4 W of power. The power was 
increased per minute up to physical exhaustion, defined 
as the moment when the volunteers were no longer able 
to maintain their pedaling rate at 60 rpm, or until the 
manifestation of any limiting symptom. The increments 
in power were determined for each individual according 
to the formula proposed by Wasserman et al.6: 
Power (W) = [(height - age). 14] - [150 + (6 . body mass)]100
Electrocardiogram and heart rate recording
During the CPET, the ECG and the CG were regis-
tered beat-by-beat by a single-channel cardiac monitor 
and processed with an analog-to-digital converter that 
acted as an interface between the cardiac monitor and 
a computer. The ECG was also registered in real time 
using the device and software CardioPerfect®.
Recording ventilatory and metabolic variables
The ventilatory and metabolic variables oxygen 
consumption (VO2), carbon dioxide production 
(VCO2), and ventilation (VE) were obtained with 
each breath throughout the CPET with a system 
that measures expired gases (CPX/D, Medical 
Graphics), duly calibrated before each test. Three 
trained observers identified the VAT using a vi-
sual graphical method to estimate disproportion-
ate VCO2 increases based on the linear increase of 
VO216,17. This method was based on the V-Slope 
method described by Beaver et al.17 . The VAT was 
considered as the average of the data obtained from 
the analyses of the three observers16,17.
The Borg CR-10 Scale
During the familiarization session, each volunteer re-
ceived instructions about the use of the Borg CR-10 
Scale18. On the course of the CPET, we asked the par-
ticipants to report their RPE-L and RPE-D at the end 
of each minute according to the scale18. After determin-
ing the VAT, the value provided by the volunteers on 
the Borg CR-10 Scale was compared.
Statistical analysis
For the continuous variables, an intergroup com-
parison was conducted through One-way ANOVA 
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and Tukey’s post hoc. For the discrete variables, we 
used Kruskal-Wallis’ and Dunn’s post hoc. Effect size 
(ES) was determined by Cohen’s F19 and classified 
as small effect (ES=0.10), moderate effect (ES=0.25) 
and large effect (ES=0.40). The analysis of covariance 
(ANCOVA) was used for the intergroup comparison 
of the variables RPE-L and RPE-D considering the 
variable power as a covariate. Bonferroni’s correction 
was applied to the multiple comparisons of the averag-
es adjusted by ANCOVA. The relation of the variables 
power, VO2 and HR with RPE-L and RPE-R was 
verified through Spearman’s correlation coefficient. 
The level of significance established was 5%.
RESULTS
The participants’ age, anthropometric and basal he-
modynamic characteristics are displayed on Table 1. 
We verified that the body mass index was lower in the 
CG compared to the CAD-G, while HR was lower 
in the CADb-G group compared to the CAD-G. 
However, no significant differences were found in re-
gards to the other variables.
Table 2 displays the values of the variables obtained at 
the peak of the CPET and at the moment of VAT. Both 
at the peak and at moment of VAT, the volunteers in the 
CG presented higher values of power, VO2, VE and HR in 
comparison to the CAD-G and the CADb-G (p<0.05). 
Also at the peak of the CPET, the CAD-G presented 
higher HR when compared to the CADb-G (p<0.05). 
In regards to the RPE-L, the CG reached higher levels 
when compared to the CADb-G (p<0.05) both at the 
peak and the VAT. In its turn, the RPE-D was not signifi-
cantly different among the groups (p>0.05). The analysis 
of ES revealed a large effect (>0.4) concerning all variables 
analyzed, with exception of the RPE-D, corroborating the 
results of the comparative analyses.
The ANCOVA did not reveal any significant differ-
ences among the groups pertaining to the variable RPE-L 
at peak (F=0.12; p=0.88; partial η2=0.01) and at the VAT 
(F=1.21; p=0.31; partial η2=0.08). In addition, we did not 
Table 1. Age and anthropometric and basal hemodynamic characteristics 
of the control group, coronary artery disease group that did not use be-
ta-blocker medication, and individuals with coronary arterial disease who 
used beta-blocker medication
CG
(n=10)
CAD-G
(n=10)
CADb-G
(n=10)
Age 53.4±3.7 56.3±5.4 56.1±9.3
Body mass (kg) 71.4±7.9 78.9±16.3 79.8±13.3
Height (cm) 170.2±5.6 167.6±7.2 168.7±8.7
BMI (kg/m²) 24.5±1.7* 28.1±4.2 27.9± 2.6
SBP (mmHg) 117±9.5 127±9.5 127±23.6
DBP (mmHg) 76±5.2 81.7±8.7 78±16.9
RR (rpm) 15±2 14±2 16±3
HR (bpm) 66±6 68±7 59±6†
Beta-blocker user no no yes
*p<0.05 CG versus CAD-G; †p<0.05 CADb-G versus CAD-G ; BMI: body mass index; SBP: systolic 
blood pressure; DBP: diastolic blood pressure; HR: heart rate; CG: control group; CAD-G: coronary 
arterial disease group; CADb-G: coronary arterial disease group with users of beta-blockers; 
RR: respiratory rate; HR: heart rate. Values in mean±standard deviation
Table 2. Variables obtained on the test of cardiopulmonary exercise at the moment when the ventilatory anaerobic threshold was reached and at 
the peak of exercise in the groups control, individuals with coronary arterial disease who did not use beta-blocker medication, and those who used 
beta-blocker medication
CG
(n=10)
CAD-G
(n=10)
CADb-G
(n=10)
F value p-value Effect size
PEAK
Power (W) 156.5±23.9*† 113.3±18.2 94.0±23.8 20.9 <0.001 1.2
VO
2 
(mL/kg/min) 26.2±5.1*† 18.6±3.9 15.9±3.4 16.2 <0.001 1.0
VCO
2 
(L/min) 2.0±0.3*† 1.5±0.2 1.2±0.3 17.6 <0.001 1.1
VE (L/min) 59.7±13.9*† 43.5±9.1 37.6±9.4 10.7 <0.001 0.9
HR (bpm) 155.5±8.9*† 132.9±18.2† 105.1±17.0 27.2 <0.001 1.6
RPE-L 7.5±1.1† 6.6±1.6 6.0±0.8 4.0 0.03 0.2
RPE-D 6.6±1.3 6.2±1.5 5.8±0.8 1.0 0.4 0.3
VAT
Power (W) 124.1±25.6*† 84.2±27.4 77.7±20.9 10.3 <0.001 0.8
VO
2 
(mL/kg/min) 21.1±5.5*† 14.4±4.7 13.6±3.4 7.9 0.002 0.7
VCO
2 
(L/min) 1.4±0.3*† 1.0±0.3 1.0±0.2 6.3 0.005 0.7
VE (L/min) 39.2±10.9*† 28.5±8.4 28.5±7.5 4.7 0.02 0.6
HR (bpm) 131.1±8.5*† 112.8±18.8 97.4±17.7 11.5 <0.001 0.9
RPE-L 6.5±1.5† 5.9±1.6 4.9±1.3 3.3 0.06 0.5
RPE-D 5.5±1.5 5.4±1.7 5.0±1.3 0.3 0.8 0.1
*p<0.05 versus CAD-G; † p<0.05 versus CADb-G; VO
2
: oxygen consumption; VCO
2
: carbon dioxide production; VE: ventilation; HR: heart rate; RPE-L: rating of perceived exertion – lower limbs; RPE-D: rating 
of perceived exertion - dyspnea ; CG: control group; CAD-G: coronary arterial disease group; CADb-G: coronary arterial disease group with users of beta-blockers; VAT: ventilatory anaerobic threshold. 
Values shown in mean±standard deviation
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identify any significant differences concerning the variable 
RPE-D at peak (F=0.07; p=0.93; partial η2 =0.006) and at 
the VAT (F=0.14; p=0.87; partial η2 =0.01).
Significant correlations were found between 
power, VO2, HR and RPE. We also observed a lin-
ear decrease of the RPE-L and RPE-D in all groups 
(Table 3 and Figure 1).
DISCUSSION
In the present study, our purpose was to identify and 
compare the values of RPE-L and RPE-D obtained at 
the VAT moment in healthy individuals and patients 
with CAD who used and did not use beta-blocker 
medication, as well as to verify the relation of the ven-
tilatory and metabolic variables and power with RPE.
The results of the present study show that the CG 
presented higher values of power and of metabolic and 
ventilatory variables in comparison to the groups CAD 
and CADb-G. However, regarding the RPE-L, the 
CADb-G showed lower VAT and peak effort values 
compared to the CG. These findings disagree with pre-
vious studies14,20 in which the authors observed an in-
crease in RPE after the use of beta-blocker medication. 
The lower values found in the CADb-G can be jus-
tified by the significant difference in the intensity of 
effort achieved by the groups at the moment of VAT. 
Recent studies have proposed that the physiological 
bases to explain the RPE are consistent with the theory 
of reafferent corollary discharge21,22. According to this 
theory, an increase in central motor commands is re-
sponsible for inciting the muscular activity necessary to 
meet the demands of the activity in progress. This in-
crease in muscle activation results in an increase in the 
shots released by neuromuscular joints, thus promoting 
feedback in the sensory areas of the brain, where this 
information is processed and RPE originates. Thus, the 
more intense the effort, the higher the RPE.
Another factor that must be considered in regards 
to the lack of difference in RPE among the groups is 
the fact that these comparisons were carried out at spe-
cific physiological moments, such as when the VAT was 
reached and at the peak of effort. Previous studies, in 
which the authors verified the influence of beta-block-
ers on RPE, the parameters of comparison used were 
pre-established intensities or a percentage determined 
in relation to maximum VO213,20.23.
With the purpose of eliminating the influence of 
different intensities on RPE, achieved at the VAT and 
at the peak of effort, we conducted the ANCOVA con-
sidering power as a covariate. After the adjustment, the 
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RPE-L: rating of perceived exertion – lower limbs; RPE-D: rating of perceived exertion - dyspnea; 
CG: control group; CAD-G: coronary arterial disease group; CADb-G: coronary arterial disease 
group with users of beta-blockers; VAT: ventilatory anaerobic threshold
Figure 1. Rating of perceived exertion of lower limbs and dyspnea in the res-
ting position, at the first increase in load, at the ventilator anaerobic threshold, 
and peak power of the groups control, coronary artery disease group without 
beta-blockers, and coronary artery disease group with users of beta-blockers
Table 3. Spearman’s correlation coefficients 
Variables RPE
CG CAD-G CADb-G
r
s
p-value r
s
p-value r
s
p-value
VO
2
 (mL/kg/min) LL 0.74 <0.0001 0.77 <0.0001 0.70 <0.0001
Dyspnea 0.79 <0.0001 0.74 <0.0001 0.56 <0.0001
HR (bpm) LL 0.82 <0.0001 0.72 <0.0001 0.61 <0.0001
Dyspnea 0.84 <0.0001 0.70 <0.0001 0.48 <0.0001
Power (W) LL 0.80 <0.0001 0.79 <0.0001 0.73 <0.0001
Dyspnea 0.84 <0.0001 0.74 <0.0001 0.64 <0.0001
RPE: rating of perceived exertion; CG: control group; CAD-G: coronary arterial disease group; CADb-G: coronary arterial disease group with users of beta-blockers; VO
2
: oxygen consumption; HR: heart rate;  
LL: lower limbs
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results did not show significant differences among 
the groups concerning RPE-L and RPE-D, which sug-
gests that the use of beta-blocker medication did not 
influence RPE at the same level of intensity.
The influence of beta-blockers in RPE is a con-
troversial topic. Although several authors have found 
that the use of beta-blocker medication promotes an 
increase in RPE13,20.23, other researchers have observed 
that this influence was absent14,24, which is in agreement 
with the findings of the present study.
The comparison of RPE at the moment of VAT and 
the present findings corroborate the results of previous 
studies10.11,25,26, in which the authors also observed simi-
lar RPE values at the anaerobic threshold of individuals 
with different characteristics, such as gender10 and level 
of physical activity11,25. 
Another important finding in our study pertains to 
the significant correlations of power, VO2 and HR with 
RPE-L and RPE-D, as they confirm the association of 
RPE with cardiopulmonary responses and workout in-
tensity. These findings corroborate those of Felts et  al.26, 
who found a significant relation between RPE and 
workout load and duration. However, it is important to 
highlight that the correlations found in the CADb-G 
were not as strong as those found in the other groups. 
These findings can be explained by the effects of be-
ta-blockers in reducing myocardial contractility, car-
diac output and HR during physical exercises27. Thus, 
the maintenance of a cardiac output that is adequate 
and compatible with the intensity of effort depends on 
compensatory adjustments in the circulatory system, 
such as an increase in stroke volume. This justifies the 
less marked association between RPE and the variables 
VO2 and HR in this group.
Another important aspect is the necessity of pa-
rameters to advise cardiopathic patients in regards to 
the unsupervised practice of physical exercise after 
discharge. Chow and Wilmore28 verified the accuracy 
of using physiological parameters to maintain HR in 
a pre-established workout zone by testing three ex-
perimental situations. In the first, the individuals were 
asked to run without feedback from the researchers. 
They were responsible for controlling their own gait ca-
dence. On their own, they were able to remain in the 
HR zone only 25% of the time. In the second situa-
tion, the volunteers were allowed to check their HR 
periodically, which raised the rate of permanence in the 
training zone to 55%. In the third experimental con-
dition, the participants were informed about the RPE 
corresponding to the training zone. A permanence rate 
of 48% was observed, not different from the accuracy 
reached by monitoring HR.
Thus, by determining the RPE that corresponds 
to the VAT, it is possible to have a safe parameter that 
complements HR monitoring and other previous ori-
entations for these patients’ supervised and unsuper-
vised training8,29.
Although the interesting results obtained in the 
present study are a starting point for future investi-
gations, some limitations should be considered. Even 
though producing a target RPE based on a test of in-
creasing effort is a valid method to prescribe workout 
intensity30-32, in this study we did not apply long pro-
tocols with constant loads. Therefore, more studies are 
necessary to verify whether the time taken to perform a 
physical activity influences RPE, and whether the phys-
iological response that corresponds to a certain RPE 
value in an incremental test differs from values achieved 
on the course of constant intensities of training.
In conclusion, the results show that the individu-
als with CAD, users and non-users of beta-blockers, 
have a similar RPE to that of healthy individuals at 
the level of VAT for the same relative power. Thus, 
values between five and six on the Borg CR-10 scale 
correspond to intensity levels close to the VAT in the 
sample studied and can be used as parameters that are 
complementary to HR monitoring when prescribing 
workout intensity on the physical training protocols of 
these individuals.
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